---
figid: PMC5817805__12943_2018_805_Fig1_HTML
figtitle: The BCR-ABL1 signaling pathways targeted by non ABL-directed inhibitors
organisms:
- NA
pmcid: PMC5817805
filename: 12943_2018_805_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5817805/figure/Fig1/
number: F1
caption: Schematic representation of the BCR-ABL1 signaling pathways targeted by non
  ABL-directed inhibitors. FT-Is (a) and mTOR-Is (b) inhibit RAS and mTOR activation
  resulting in cell proliferation arrest; Smo-As (c) inhibit the Hedgeohg signaling
  and reduce self-renewal, survival and cell proliferation; JAK-Is (d) suppress JAK2/STATs
  pathway reducing cell survival; Hsp-90-Is (e) reduce BCR-ABL1 half-life inducing
  its degradation; HDAC-Is (f) modify the histone acetylation state regulating gene
  expression; Sirt-Is (g) suppress the deacetylation activity of SIRT1; BCL2-Is (h) block
  the pro-survival activity of BCL-2 family members increasing apoptosis; AURK-Is
  (i) block the mitotic process by inhibiting of AURKs
papertitle: Non ABL-directed inhibitors as alternative treatment strategies for chronic
  myeloid leukemia.
reftext: Michele Massimino, et al. Mol Cancer. 2018;17:56.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9076706
figid_alias: PMC5817805__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC5817805__F1
ndex: 100acd0c-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5817805__12943_2018_805_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of the BCR-ABL1 signaling pathways targeted
    by non ABL-directed inhibitors. FT-Is (a) and mTOR-Is (b) inhibit RAS and mTOR
    activation resulting in cell proliferation arrest; Smo-As (c) inhibit the Hedgeohg
    signaling and reduce self-renewal, survival and cell proliferation; JAK-Is (d)
    suppress JAK2/STATs pathway reducing cell survival; Hsp-90-Is (e) reduce BCR-ABL1
    half-life inducing its degradation; HDAC-Is (f) modify the histone acetylation
    state regulating gene expression; Sirt-Is (g) suppress the deacetylation activity
    of SIRT1; BCL2-Is (h) block the pro-survival activity of BCL-2 family members
    increasing apoptosis; AURK-Is (i) block the mitotic process by inhibiting of AURKs
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - BCR
  - RN7SL263P
  - ABL1
  - MTTP
  - DSP-AS1
  - ABL2
  - JAK2
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - GAB2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - SMO
  - SMOX
  - SIRT1
  - GLI1
  - TP53
  - TP63
  - TP73
  - TMPRSS11D
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - BCL2
  - BCL2L1
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - Hsp83
  - Gp93
  - RhoGAP1A
  - Abl
  - drk
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - MKP-4
  - p38b
  - rl
  - Akt
  - Mtor
  - Tor
  - smo
  - sm
  - Sirt1
  - p53
  - betaTub60D
  - hth
  - hat
  - Elp3
  - CG1894
  - chm
  - Debcl
  - Tyr
  - Mitosis
---
